Reaching the holy grail of precision medicine

Irish company Diaceutics is at the centre of a high-tech revolution in personalised medicine that promises fast and more effective treatments

23rd April, 2017
Peter Keeling, chief executive, Diaceutics

Pharmaceuticals is not an industry that moves forward in straight lines. Massive leaps in the lab have in the past been followed by blockbuster drugs, as well as by long periods of unfulfilled promise.

Precision medicine – the dream of medicine tailored to the specific, individual needs of patients and groups of patients – has long promised not only the next great leap forward, but also an end to the dry spells. That era may...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Enthusiasm for digital change exists way beyond the IT team

Is your company data safe?

Interxion-DLR provides data centres for the support of active Public Cloud platforms

Construction is the least digitised sector